: Primary mucosal melanomas (MMs) are uncommon tumors originating from melanocytes located in the mucous membranes at various anatomic sites within the body. MM significantly differs from cutaneous melanoma (CM) regarding epidemiology, genetic profile, clinical presentation, and response to therapies. Despite these differences, that have important implications for both disease diagnosis and prognosis, MMs are usually treated in the same way as CM but exhibit a lower response rate to immunotherapy leading to a poorer survival rate. Furthermore, a high inter-patient variability can be observed in relation to therapeutic response. Recently, novel "omics" techniques have evidenced that MM lesions have different genomic, molecular, and metabolic landscapes as compared with CM lesions, thus explaining the heterogeneity of the response. Such specific molecular aspects might be useful to identify new biomarkers aimed at improving the diagnosis and selection of MM patients who could benefit from immunotherapy or targeted therapy. In this review, we have focused on relevant molecular and clinical advancements for the different MM subtypes in order to describe the updated knowledge relating to main diagnostic, clinical, and therapeutic implications as well as to provide hints on likely future directions.

Current Trends in Mucosal Melanomas: An Overview / Santeufemia, Davide Adriano; Palmieri, Giuseppe; Miolo, Gianmaria; Colombino, Maria; Doro, Maria Grazia; Frogheri, Laura; Paliogiannis, Panagiotis; Capobianco, Giampiero; Madonia, Massimo; Cossu, Antonio; Lo Re, Giovanni; Corona, Giuseppe. - In: CANCERS. - ISSN 2072-6694. - 15:5(2023), pp. 1356-1373. [10.3390/cancers15051356]

Current Trends in Mucosal Melanomas: An Overview

Palmieri, Giuseppe
Conceptualization
;
Paliogiannis, Panagiotis
Membro del Collaboration Group
;
Capobianco, Giampiero
Membro del Collaboration Group
;
Madonia, Massimo
Membro del Collaboration Group
;
Cossu, Antonio
Membro del Collaboration Group
;
2023-01-01

Abstract

: Primary mucosal melanomas (MMs) are uncommon tumors originating from melanocytes located in the mucous membranes at various anatomic sites within the body. MM significantly differs from cutaneous melanoma (CM) regarding epidemiology, genetic profile, clinical presentation, and response to therapies. Despite these differences, that have important implications for both disease diagnosis and prognosis, MMs are usually treated in the same way as CM but exhibit a lower response rate to immunotherapy leading to a poorer survival rate. Furthermore, a high inter-patient variability can be observed in relation to therapeutic response. Recently, novel "omics" techniques have evidenced that MM lesions have different genomic, molecular, and metabolic landscapes as compared with CM lesions, thus explaining the heterogeneity of the response. Such specific molecular aspects might be useful to identify new biomarkers aimed at improving the diagnosis and selection of MM patients who could benefit from immunotherapy or targeted therapy. In this review, we have focused on relevant molecular and clinical advancements for the different MM subtypes in order to describe the updated knowledge relating to main diagnostic, clinical, and therapeutic implications as well as to provide hints on likely future directions.
2023
Current Trends in Mucosal Melanomas: An Overview / Santeufemia, Davide Adriano; Palmieri, Giuseppe; Miolo, Gianmaria; Colombino, Maria; Doro, Maria Grazia; Frogheri, Laura; Paliogiannis, Panagiotis; Capobianco, Giampiero; Madonia, Massimo; Cossu, Antonio; Lo Re, Giovanni; Corona, Giuseppe. - In: CANCERS. - ISSN 2072-6694. - 15:5(2023), pp. 1356-1373. [10.3390/cancers15051356]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/304127
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact